Expert Discusses Pulmonary Nodules and Lung Cancer Screening

OSUWexnerbloglogo2014 Expert Discusses Pulmonary Nodules and Lung Cancer Screening. Today on MedNet21, we are going to help you use the chest CT in your own clinical practice in order to save lives. My guest is pulmonologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Mike Wert.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: develop an evidence-based approach to the management of solitary pulmonary nodules; and understand the evidence behind and the importance of lung cancer screening in high-risk patients.

You’ll also learn about the following:

  • Efficacy of lung cancer screening
  • Challenges with lung cancer screening?

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Multiple Sclerosis

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Multiple Sclerosis. Over the past 25 years, there have been dramatic new developments in how we treat multiple sclerosis and this is giving hope to patients who on the past had very few options. Here today to bring us up to date on the latest developments in multiple sclerosis is the Chairman of the OSU Department of Neurology, Dr. Benjamin Segal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN about the typicalclinical course of multiple sclerosis and disease modifying treatments; and LEARN about our current understanding of the pathogenesis of MS.

You’ll also learn about the following:

  • Common signs and symptoms of multiple sclerosis
  • Current concepts in multiple sclerosis treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Interstitial Lung Disease

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Interstitial Lung Disease. Once each year, I exercise moderator’s privileges and serve as both host and presenter and so today, I’m going to be talking about a topic that is important to me, namely interstitial lung disease.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY patients with undiagnosed interstitial lung disease based on clinical, radiographic, and pulmonary function test presentations; DISTINGUISH idiopathic pulmonary fibrosis from other common interstitial diseases based on radiographic and pathologic findings; and DESCRIBE the initial management of common interstitial lung diseases including idiopathic pulmonary fibrosis, non-specific interstitial pneumonitis,
hypersensitivity pneumonitis, and sarcoidosis.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Educates Learners on Lung Cancer Staging

OSUWexnerbloglogo2014 CME Webcast Educates Learners on Lung Cancer Staging. On this program, we’re going to update you on the approach to lung cancer staging. Joining on moderator is our lung cancer expert from the Division of Hematology and Medical Oncology, Clinical Instructor of Internal Medicine, Dr. Jean Bustamante Alvarez.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the importance of lung cancer staging and the need for a multidisciplinary approach; and IDENTIFY the minimally necessary studies that will be necessary to stage a patient with lung cancer.

You’ll also learn about the following:

  • Racial disparities in lung cancer diagnosis and survival
  • Staging small cell lung cancer
  • Surgery versus stereotactic ablative radiotherapy
  • Stereotactic ablative radiotherapy
  • When PET-CT can miss lung cancer

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.